{"entity":{"type":"insider","cik":"0001806992","url":"/insider/0001806992","json_url":"/insider/0001806992.json","name":"Clowes Howard","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2021-03-04","last":"2024-09-13","span_basis":"filed_date"},"name_variants":[{"name":"Clowes Howard","source":"filing","n_filings":7,"first_seen":"2021-03-04","last_seen":"2024-09-13"}],"transactions":[{"id":3216977,"accession":"0000950170-24-106179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-106179","line_url":"/filing/0000950170-24-106179#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001806992","owner_name":"Clowes Howard","owner_display_name":"Clowes Howard","owner_url":"/insider/0001806992","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.3362,"price_display":"1.34","price_state":"stated","total_value":6681.0,"total_display":"6,681.00","total_whole":"6,681","shares_owned_after":26497.0,"shares_owned_after_display":"26,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-13","scope":"insider"},{"id":2116560,"accession":"0000950170-24-057452","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-057452","line_url":"/filing/0000950170-24-057452#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001806992","owner_name":"Clowes Howard","owner_display_name":"Clowes Howard","owner_url":"/insider/0001806992","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9804.0,"shares_display":"9,804","price_per_share":2.04,"price_display":"2.04","price_state":"stated","total_value":20000.16,"total_display":"20,000.16","total_whole":"20,000","shares_owned_after":21497.0,"shares_owned_after_display":"21,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-08","filed_date":"2024-05-10","scope":"insider"},{"id":8726846,"accession":"0001209191-23-049535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049535","line_url":"/filing/0001209191-23-049535#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001806992","owner_name":"Clowes Howard","owner_display_name":"Clowes Howard","owner_url":"/insider/0001806992","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6993.0,"shares_display":"6,993","price_per_share":1.4331,"price_display":"1.43","price_state":"stated","total_value":10021.6683,"total_display":"10,021.67","total_whole":"10,022","shares_owned_after":11693.0,"shares_owned_after_display":"11,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-13","filed_date":"2023-09-15","scope":"insider"},{"id":8723881,"accession":"0001209191-23-035267","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-035267","line_url":"/filing/0001209191-23-035267#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001806992","owner_name":"Clowes Howard","owner_display_name":"Clowes Howard","owner_url":"/insider/0001806992","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":3.98,"price_display":"3.98","price_state":"stated","total_value":3980.0,"total_display":"3,980.00","total_whole":"3,980","shares_owned_after":4700.0,"shares_owned_after_display":"4,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-08","scope":"insider"},{"id":8293969,"accession":"0001209191-23-027213","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-027213","line_url":"/filing/0001209191-23-027213#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001806992","owner_name":"Clowes Howard","owner_display_name":"Clowes Howard","owner_url":"/insider/0001806992","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":3.6406,"price_display":"3.64","price_state":"stated","total_value":9101.5,"total_display":"9,101.50","total_whole":"9,102","shares_owned_after":3700.0,"shares_owned_after_display":"3,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-03","filed_date":"2023-05-04","scope":"insider"},{"id":6672023,"accession":"0001209191-22-034420","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-034420","line_url":"/filing/0001209191-22-034420#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001806992","owner_name":"Clowes Howard","owner_display_name":"Clowes Howard","owner_url":"/insider/0001806992","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.5726,"price_display":"0.57","price_state":"stated","total_value":8589.0,"total_display":"8,589.00","total_whole":"8,589","shares_owned_after":18000.0,"shares_owned_after_display":"18,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-06","scope":"insider"},{"id":4224135,"accession":"0001209191-21-017597","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-017597","line_url":"/filing/0001209191-21-017597#line-1","is_derivative":false,"issuer_cik":"0001095981","issuer_name":"PLUS THERAPEUTICS, INC.","issuer_ticker":"PSTV","issuer_name_source":null,"issuer_url":"/issuer/0001095981","owner_cik":"0001806992","owner_name":"Clowes Howard","owner_display_name":"Clowes Howard","owner_url":"/insider/0001806992","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.42,"price_display":"2.42","price_state":"stated","total_value":7260.0,"total_display":"7,260.00","total_whole":"7,260","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001095981","name":"PLUS THERAPEUTICS, INC.","url":"/issuer/0001095981","role":"Director","n_filings":7,"first_seen":"2021-03-04","last_seen":"2024-09-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001806992","retrieved_at":"2026-08-25T18:53:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}